Gotowa bibliografia na temat „Oxaliplatin”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Oxaliplatin”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Oxaliplatin"
Ye, Tong, Chen Wu, Jintong Na, Xiyu Liu, and Yong Huang. "Multi-Pathway Study for Oxaliplatin Resistance Reduction." Current Issues in Molecular Biology 47, no. 3 (2025): 172. https://doi.org/10.3390/cimb47030172.
Pełny tekst źródłaAin, Noor ul, Nusrat Bano, Anwar Ejaz Beg, Kamran Hameed, Talha Bin Fayyaz, and Rafia Sadaf. "HEMATOLOGICAL TOXICITY IN RATS;." Professional Medical Journal 24, no. 02 (2017): 342–46. http://dx.doi.org/10.29309/tpmj/2017.24.02.525.
Pełny tekst źródłaGrothey, A., D. A. Nikcevich, J. A. Sloan, et al. "Evaluation of the effect of intravenous calcium and magnesium (CaMg) on chronic and acute neurotoxicity associated with oxaliplatin: Results from a placebo-controlled phase III trial." Journal of Clinical Oncology 27, no. 15_suppl (2009): 4025. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.4025.
Pełny tekst źródłaPires, Lívia Márcia Vidal, and Patrícia Dos Santos Claro Fuly. "Mapeamento de fatores clínicos preditivos da neuropatia sensorial periférica induzida por oxaliplatina: revisão sistemática." Revista Recien - Revista Científica de Enfermagem 11, no. 35 (2021): 382–97. http://dx.doi.org/10.24276/rrecien2021.11.35.382-397.
Pełny tekst źródłaCho, Soohee, Kristen Miller, Jacqueline Rowley, et al. "OTHR-03. Oxaliplatin as a hearing-sparing alternative to carboplatin in tandem autologous stem cell transplants in pediatric CNS malignancy." Neuro-Oncology 24, Supplement_1 (2022): i147. http://dx.doi.org/10.1093/neuonc/noac079.542.
Pełny tekst źródłaConnors, Jeremy S., Linda Zhang, Koji Sasaki, et al. "Protective Role of Oxaliplatin Among Platinum-Based Therapies in the Development of Therapy-Related Myeloid Neoplasms." Blood 142, Supplement 1 (2023): 4220. http://dx.doi.org/10.1182/blood-2023-190672.
Pełny tekst źródłaLipp and Hartmann. "Platinverbindungen: Metabolismus, Toxizität und supportive Strategien." Praxis 94, no. 6 (2005): 187–98. http://dx.doi.org/10.1024/0369-8394.94.6.187.
Pełny tekst źródła&NA;. "Oxaliplatin." Reactions Weekly &NA;, no. 1378 (2011): 27. http://dx.doi.org/10.2165/00128415-201113780-00098.
Pełny tekst źródła&NA;. "Oxaliplatin." Reactions Weekly &NA;, no. 1384 (2012): 43. http://dx.doi.org/10.2165/00128415-201213840-00174.
Pełny tekst źródła&NA;. "Oxaliplatin." Reactions Weekly &NA;, no. 1385 (2012): 35. http://dx.doi.org/10.2165/00128415-201213850-00129.
Pełny tekst źródłaRozprawy doktorskie na temat "Oxaliplatin"
Xiaoqing, Liu. "Dose-banding studies on oxaliplatin." Thesis, University of Plymouth, 2016. http://hdl.handle.net/10026.1/8081.
Pełny tekst źródłaVincent, Jacob Adam. "Sensorimotor Deficits Following Oxaliplatin Chemotherapy." Wright State University / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=wright1496136263522854.
Pełny tekst źródłaWieczerzak, Krystyna Blanka. "Sensorimotor Analysis of Oxaliplatin Treated Rats." Wright State University / OhioLINK, 2015. http://rave.ohiolink.edu/etdc/view?acc_num=wright1432856752.
Pełny tekst źródłaRobinson, Stuart Michael. "The pathogenesis of oxaliplatin induced sinusoidal obstruction syndrome." Thesis, University of Newcastle upon Tyne, 2013. http://hdl.handle.net/10443/1942.
Pełny tekst źródłaMONZA, LAURA. "In vitro models for studying oxaliplatin neurotoxic effects." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2019. http://hdl.handle.net/10281/241333.
Pełny tekst źródłaCerles, Olivier. "Prévention des neuropathies périphériques induites par les chimiothérapies par une modulation pharmacologique des dérives des formes réactives de l'oxygène et des récepteurs muscariniques." Thesis, Sorbonne Paris Cité, 2017. http://www.theses.fr/2017USPCB106.
Pełny tekst źródłaAzarm, Asieh. "Effect of oxaliplatin on HCT116 P53+/- colon cancer cells." Thesis, Högskolan i Skövde, Institutionen för vård och natur, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-5451.
Pełny tekst źródłaGolf, Alexander. "Eine randomisierte Phase-II-Studie mit Capecitabin/Oxaliplatin versus Gemcitabin/Capecitabin versus Gemcitabin/Oxaliplatin bei Patienten mit lokal fortgeschrittenem inoperablem oder metastasiertem Pankreaskarzinom." Diss., lmu, 2009. http://nbn-resolving.de/urn:nbn:de:bvb:19-108951.
Pełny tekst źródłaPOZZI, ELEONORA. "OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY IN MOUSE MODELS: DIFFERENT TREATMENT SCHEDULES AND FOCUS ON OXIDATIVE STRESS." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2020. http://hdl.handle.net/10281/261949.
Pełny tekst źródłaGong, Peng Chaney Stephen G. "Modeling conformational dynamics of cisplatin and oxaliplatin adducts with DNA." Chapel Hill, N.C. : University of North Carolina at Chapel Hill, 2006. http://dc.lib.unc.edu/u?/etd,496.
Pełny tekst źródłaKsiążki na temat "Oxaliplatin"
National Institute for Clinical Excellence. Guidance on the use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. NICE, 2002.
Znajdź pełny tekst źródłaM, Lloyd Jones, and National Co-ordinating Centre for HTA (Great Britain), eds. A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. Core Research on behalf of NCCHTA, 2001.
Znajdź pełny tekst źródłaLloyd, Jones M., National Co-ordinating Centre for HTA (Great Britain), and Health Technology Assessment Programme, eds. A Rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. NCCHTA, 2001.
Znajdź pełny tekst źródłaR, Kelland Lloyd, and Farrell Nicholas 1948-, eds. Platinum-based drugs in cancer therapy. Humana Press, 2000.
Znajdź pełny tekst źródłaMarshall, John L. The Clinical Use of Oxaliplatin: Case Studies and Roundtable Discussion, Including a Clinical Discussion on Audio CD. Cmp United Business Media, 2004.
Znajdź pełny tekst źródłaSchmoll, H. J. Oxaliplatin (eloxatin): Fortschritte In Der Tumortherapie 2004 (Onkologie). S Karger Pub, 2004.
Znajdź pełny tekst źródłaSchmoll, H. J. Oxaliplatin (Eloxatin): Fortschritte in Der Tumortherapie (Onkologie). S Karger Pub, 2000.
Znajdź pełny tekst źródłaMcLeon, Kelly. Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer. Edited by SreyRam Kuy and Miguel A. Burch. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199384075.003.0011.
Pełny tekst źródłaPublications, ICON Health. Oxaliplatin - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.
Znajdź pełny tekst źródłaCzęści książek na temat "Oxaliplatin"
Mader, Ines, Patrizia Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, and Sabine M. Wassertheurer. "Oxaliplatin." In Paravasation von Zytostatika. Springer Vienna, 2002. http://dx.doi.org/10.1007/978-3-7091-3799-4_40.
Pełny tekst źródłaMader, Ines, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz, and Sabine Wassertheurer. "Oxaliplatin." In Extravasation of Cytotoxic Agents. Springer Vienna, 2010. http://dx.doi.org/10.1007/978-3-211-88893-3_47.
Pełny tekst źródłaMader, Ines, Patrizia E. Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, and Sabine M. Wassertheurer. "Oxaliplatin." In Extravasation of Cytotoxic Agents. Springer Vienna, 2003. http://dx.doi.org/10.1007/978-3-7091-3710-9_40.
Pełny tekst źródłaBonetti, Andrea, and Furini Lara. "Oxaliplatin-Based Chemotherapy for Colon Cancer." In Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-459-3_31.
Pełny tekst źródłaStein, Alexander. "Oxaliplatin, Clinical Use in Cancer Patients." In Encyclopedia of Metalloproteins. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-1533-6_563.
Pełny tekst źródłaTaguchi, T. "Clinical Trials of Oxaliplatin and DWA2114R." In Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2. Springer US, 1996. http://dx.doi.org/10.1007/978-1-4899-0218-4_19.
Pełny tekst źródłaAschele, Carlo, Elisa Bennicelli, and Amalia Milano. "Should Oxaliplatin Be Added to Preoperative Chemoradiation?" In Multidisciplinary Management of Rectal Cancer. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-43217-5_35.
Pełny tekst źródłaJacobson, Stacy D., Steven R. Alberts, and Richard M. Goldberg. "Oxaliplatin in the Treatment of Colorectal Cancer." In Colorectal Cancer. Humana Press, 2002. http://dx.doi.org/10.1007/978-1-59259-160-2_29.
Pełny tekst źródłaAschele, Carlo. "Should Oxaliplatin Be Added to Preoperative Chemoradiation?" In Multidisciplinary Management of Rectal Cancer. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-25005-7_18.
Pełny tekst źródłaGatti, Laura, and Paola Perego. "Cellular Resistance to Oxaliplatin and Drug Accumulation Defects." In Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-459-3_16.
Pełny tekst źródłaStreszczenia konferencji na temat "Oxaliplatin"
Farrukh, A., and W. Mickey. "Interstitial Pneumonitis From Gemcitabine and Oxaliplatin Combination." In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3171.
Pełny tekst źródłaJungwirth, Ute, Petra Heffeter, Johannes Gojo, et al. "Abstract C93: Novel monosubstituted oxaliplatin analogs with improved characteristics." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/1535-7163.targ-09-c93.
Pełny tekst źródłaKuang, Yuting, Anthony El-Khoueiry, Pietro Taverna, Mats Ljungman, and Nouri Neamati. "Abstract 2533: SGI-110 priming sensitizes hepatocellular carcinoma cells to oxaliplatin." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-2533.
Pełny tekst źródłaChen, Yufeng, Zhaoliang Yu, Peng Deng, and Xiaojian Wu. "Abstract 972: Pharmacological targeting CDC7 sensitizes oxaliplatin treatment in colorectal cancer." In Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-972.
Pełny tekst źródłaDosualdo, Caique Alberto. "Reversible posterior encephalopathy syndrome as a rare complication of oxaliplatin chemotherapy: a case report." In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.399.
Pełny tekst źródłaWu, Xiaojun, E. Yiwen, Xinlong Xu, and Li Wang. "Interaction between DNA and Oxaliplatin in Aqueous Solution Studied Using THz-TDS." In Laser and Tera-Hertz Science and Technology. OSA, 2012. http://dx.doi.org/10.1364/ltst.2012.sf2a.3.
Pełny tekst źródłaFortuna, M., P. Tavcar, M. Sonc, et al. "5PSQ-056 Evaluation of oxaliplatin-specific neurotoxicity based on total cumulative dose." In Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.410.
Pełny tekst źródłaMcIntyre, Alexander, Fiammetta Falcone, Patrick G. Johnston, Daniel B. Longley, and Simon S. McDade. "Abstract LB-016: Nutlin and oxaliplatin induce p53-dependent addiction to FLIP." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-lb-016.
Pełny tekst źródłaHuang, Huakang, and Daniel W. Rosenberg. "Abstract 3608: Prostaglandin E-2 promotes resistance to oxaliplatin in colorectal cancer cells." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-3608.
Pełny tekst źródłaSorensen, Kathleen, Jennifer Jess, Susan Goosen, et al. "Abstract 5817: Oxaliplatin and ATR inhibitors show strong synergy in Ewing sarcoma cells." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-5817.
Pełny tekst źródłaRaporty organizacyjne na temat "Oxaliplatin"
Si, Yue, Yan Yuan, Yihua Zou, Haiyan Wang, and Yong Xin. S-1 or Capecitabine in combination with Oxaliplatin for Gastric Cancer:A meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.1.0064.
Pełny tekst źródłaZhou, Tong, Shuo Wang, Lanxin Zhang, et al. Efficacy and Safety of Compound Kushen Injection Combined With Oxaliplatin-Based Chemotherapy in the Treatment of Advanced Colorectal Cancer: a Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.9.0059.
Pełny tekst źródłaJing, Hailiang, Jianing Jian, Hong Liu, et al. The effect of oral Chinese herbal medicine on Oxaliplatin-induced Peripheral Neuropathy in patients with advanced colorectal cancer treated with FOLFOX: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.12.0124.
Pełny tekst źródłaWang, Shuo, Xueqian Wang, Tong Zhou, et al. Efficacy of Chinese herbal injections combined with fluoropyrimidine and oxaliplatin-based chemotherapy for advanced colorectal cancer: a protocol for systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.10.0050.
Pełny tekst źródła